{
    "output": [
        [
            "AOBiome Therapeutics",
            "ORG",
            "Announce",
            "Todd Krueger",
            "PERSON"
        ],
        [
            "Todd Krueger",
            "PERSON",
            "Retains",
            "President",
            "ORG"
        ],
        [
            "Todd Krueger",
            "PERSON",
            "Named",
            "CEO",
            "ORG"
        ],
        [
            "AOBiome",
            "ORG",
            "Operate_In",
            "Massachusetts",
            "GPE"
        ],
        [
            "AOBiome",
            "ORG",
            "Advancing",
            "Patented Microbiome-Targeted Therapies",
            "CONCEPT"
        ],
        [
            "AOBiome",
            "ORG",
            "Has",
            "Multiple Mid-Clinical Stage Programs",
            "CONCEPT"
        ],
        [
            "AOBiome",
            "ORG",
            "Expect",
            "Key Data Readouts",
            "CONCEPT"
        ],
        [
            "AOBiome",
            "ORG",
            "Has",
            "First-In-Class Ammonia Oxidizing Bacteria (AOB) Platform",
            "CONCEPT"
        ],
        [
            "Jamie Heywood",
            "PERSON",
            "Chairman",
            "AOBiome",
            "ORG"
        ],
        [
            "Jamie Heywood",
            "PERSON",
            "Co-Founder",
            "AOBiome",
            "ORG"
        ],
        [
            "Todd Krueger",
            "PERSON",
            "Exemplary Track Record",
            "null"
        ],
        [
            "Todd Krueger",
            "PERSON",
            "Unique Expertise",
            "Healthcare Strategy, Business Development, Operations"
        ],
        [
            "Todd Krueger",
            "PERSON",
            "Join",
            "AOBiome",
            "ORG"
        ],
        [
            "Todd Krueger",
            "PERSON",
            "Prior",
            "Head of Commercial Strategy and Operations",
            "Broad Institute"
        ],
        [
            "Todd Krueger",
            "PERSON",
            "Held",
            "Senior Positions",
            "Life Technologies"
        ],
        [
            "Todd Krueger",
            "PERSON",
            "Involved",
            "Founding",
            "Several Biotechnology Companies"
        ],
        [
            "Todd Krueger",
            "PERSON",
            "Co-Founded",
            "Fluidigm Corporation",
            "COMP"
        ],
        [
            "Todd Krueger",
            "PERSON",
            "Member",
            "Board of Directors",
            "Multiple Companies"
        ],
        [
            "Todd Krueger",
            "PERSON",
            "Graduated",
            "Northwestern University"
        ],
        [
            "Todd Krueger",
            "PERSON",
            "Earned",
            "MBA",
            "Kellogg School of Management"
        ],
        [
            "AOBiome",
            "ORG",
            "Focused",
            "Transforming Human Health",
            "CONCEPT"
        ],
        [
            "AOBiome",
            "ORG",
            "Developing",
            "Microbiome-Targeted Therapies",
            "CONCEPT"
        ],
        [
            "AOBiome",
            "ORG",
            "Targeting",
            "Local, Nasal and Systemic Inflammatory Conditions",
            "CONCEPT"
        ],
        [
            "AOBiome",
            "ORG",
            "Advancing",
            "Pipeline",
            "CONCEPT"
        ],
        [
            "AOBiome",
            "ORG",
            "Has",
            "Three Clinical-Stage Programs",
            "CONCEPT"
        ],
        [
            "AOBiome",
            "ORG",
            "Has",
            "Phase 2b Study",
            "CONCEPT"
        ],
        [
            "AOBiome",
            "ORG",
            "Has",
            "Phase 2 Trial",
            "CONCEPT"
        ],
        [
            "AOBiome",
            "ORG",
            "Has",
            "Phase 1b/2a Clinical Trial",
            "CONCEPT"
        ],
        [
            "AOBiome",
            "ORG",
            "Has",
            "Earlier-Stage Preclinical Programs",
            "CONCEPT"
        ],
        [
            "AOBiome",
            "ORG",
            "Targeting",
            "Diverse Inflammatory Indications",
            "CONCEPT"
        ]
    ]
}